National trends in intestinal resection for Crohn's disease in the post-biologic era

International Journal of Colorectal Disease

Volumn 28, Issue 10, 2013, Pages 1401-1406

  Burke, John P ^a   Velupillai, Yoga ^b   O'Connell, P Ronan ^c   Coffey, J Calvin ^a,b,d  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Biologic; Crohn's disease; Epidemiology; Infliximab; Surgery

Indexed keywords

BIOLOGICAL PRODUCT;

ARTICLE; COLON SURGERY; CROHN DISEASE; EMERGENCY TREATMENT; FEMALE; HEMICOLECTOMY; HOSPITAL ADMISSION; HUMAN; INTESTINE RESECTION; IRELAND; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROCTOCOLECTOMY; SMALL INTESTINE RESECTION; TOTAL COLON RESECTION; TREND STUDY;

BIOLOGICAL FACTORS; COLECTOMY; COLON; CROHN DISEASE; FEMALE; HOSPITALIZATION; HUMANS; IRELAND; MALE;

EID: 84884982310     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1698-5     Document Type: Article

References (25)

1. Van Assche G, Vermeire S, Rutgeerts P (2010) The potential for disease modification in Crohn's disease. Nat Rev Gastroenterol Hepatol 7(2):79-85
2. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al (2002) Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359(9317):1541-1549
3. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN et al (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350(9):876-885
4. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, O'Connell PR (2007) Fibrogenesis in Crohn's disease. Am J Gastroenterol 102(2):439-448
5. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T (2001) Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121(5):1145-1157
6. Rutgeerts P, Van Assche G, Sandborn WJ, Wolf DC, Geboes K, Colombel JF et al (2012) Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 142(5):1102-11 e2
7. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W (2006) American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130(3):935-939
8. Behm BW, Bickston SJ (2008) Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 1:CD006893
9. Feagan BG, Lemann M, Befrits R, Connell W, D'Haens G, Ghosh S et al (2012) Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. Inflammatory bowel diseases 18(1):152-160
10. Rubenstein JH, Chong RY, Cohen RD (2002) Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol 35(2):151-156
11. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB (2010) Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 59(9):1200-1206
12. Jones DW, Finlayson SR (2010) Trends in surgery for Crohn's disease in the era of infliximab. Ann Surg 252(2):307-312
13. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54(2):237-241
14. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR (2007) Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflammatory bowel diseases 13(12):1529-1535
15. Slattery E, Keegan D, Hyland J, O'Donoghue D, Mulcahy HE (2011) Surgery, Crohn's disease, and the biological era: has there been an impact? J Clin Gastroenterol 45(8):691-693
16. Quan H, Parsons GA, Ghali WA (2004) Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Medical Care 42(8):801-809
17. Bewtra M, Su C, Lewis JD (2007) Trends in hospitalization rates for inflammatory bowel disease in the United States. Clinical Gastroenterol Hepatol 5(5):597-601, The official clinical practice journal of the American Gastroenterological Association
18. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F (1997) Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery 122(4):661-667, discussion 67-8
19. Prabhakar LP, Laramee C, Nelson H, Dozois RR (1997) Avoiding a stoma: role for segmental or abdominal colectomy in Crohn's colitis. Dis Colon Rectum 40(1):71-78
20. Andersson P, Olaison G, Bodemar G, Nystrom PO, Sjodahl R (2002) Surgery for Crohn colitis over a twenty-eight-year period: fewer stomas and the replacement of total colectomy by segmental resection. Scand J Gastroenterol 37(1):68-73
21. Tekkis PP, Purkayastha S, Lanitis S, Athanasiou T, Heriot AG, Orchard TR et al (2006) A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis. Colorectal Dis 8(2):82-90, The official journal of the Association of Coloproctology of Great Britain and Ireland
22. Tang DH, Armstrong EP, Lee JK (2012) Cost-utility analysis of biologic treatments for moderate-to-severe Crohn's disease. Pharmacotherapy 32(6):515-526
23. D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H et al (2008) Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371(9613):660-667
24. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D et al (2010) Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 362(15):1383-1395
25. Anjum A, von Allmen R, Greenhalgh R, Powell JT (2012) Explaining the decrease in mortality from abdominal aortic aneurysm rupture. Br J Surg 99(5):637-645